Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT07192471 2026-04-20

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT07518329 2026-04-08

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

Phase 1 Not yet recruiting

46 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT07509151 2026-04-03

SOUNDTRACK-C1

Phase 3 Not yet recruiting

420 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, B-Cell

NCT07333469 2026-01-13

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

Phase 1/2 Not yet recruiting

70 enrolled

Lymphoid

Lymphoma

NCT07244380 2025-11-24

Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.

Phase 2 Not yet recruiting

38 enrolled

Lymphoid

Lymphoma

NCT07196111 2025-09-29

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Phase EARLY_PHASE1 Not yet recruiting

12 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

Phase 1/2 Not yet recruiting

116 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07048353 2025-07-02

CAR-T，MTD

Phase EARLY_PHASE1 Not yet recruiting

15 enrolled

Lymphoid

Lymphoma, Lymphoma, B-Cell

NCT05979857 2023-11-22

Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase EARLY_PHASE1 Not yet recruiting

72 enrolled

Lymphoid

Lymphoma

NCT06070246 2023-10-06

Navigating the Clinical Research Process for Lymphoma

Not yet recruiting

500 enrolled

Lymphoid

Lymphoma

NCT05788107 2023-08-09

Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma

Phase 1 Not yet recruiting

30 enrolled

Lymphoid

Lymphoma

NCT05055791 2021-09-24

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies

Phase 1/2 Not yet recruiting

312 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Leukemia, Myeloid, Acute

Clinical Trials

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

SOUNDTRACK-C1

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

CAR-T，MTD

Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

Navigating the Clinical Research Process for Lymphoma

Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies